These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 15813990)
1. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. Anderson J; Akkina R AIDS Res Ther; 2005 Jan; 2(1):1. PubMed ID: 15813990 [TBL] [Abstract][Full Text] [Related]
2. CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection. Anderson J; Akkina R Retrovirology; 2005 Aug; 2():53. PubMed ID: 16109172 [TBL] [Abstract][Full Text] [Related]
3. Stable gene transfer of CCR5 and CXCR4 siRNAs by sleeping beauty transposon system to confer HIV-1 resistance. Tamhane M; Akkina R AIDS Res Ther; 2008 Jul; 5():16. PubMed ID: 18667075 [TBL] [Abstract][Full Text] [Related]
4. Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance. Anderson J; Banerjea A; Akkina R Oligonucleotides; 2003; 13(5):303-12. PubMed ID: 15000821 [TBL] [Abstract][Full Text] [Related]
5. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection. Anderson J; Akkina R Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795 [TBL] [Abstract][Full Text] [Related]
6. Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA. Anderson J; Banerjea A; Planelles V; Akkina R AIDS Res Hum Retroviruses; 2003 Aug; 19(8):699-706. PubMed ID: 13678472 [TBL] [Abstract][Full Text] [Related]
7. Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors. Toma J; Whitcomb JM; Petropoulos CJ; Huang W AIDS; 2010 Sep; 24(14):2181-6. PubMed ID: 20639728 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4. Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840 [TBL] [Abstract][Full Text] [Related]
9. Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism. Yi Y; Isaacs SN; Williams DA; Frank I; Schols D; De Clercq E; Kolson DL; Collman RG J Virol; 1999 Sep; 73(9):7117-25. PubMed ID: 10438797 [TBL] [Abstract][Full Text] [Related]
10. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice. Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932 [TBL] [Abstract][Full Text] [Related]
11. Development of Lentiviral Vectors Simultaneously Expressing Multiple siRNAs Against CCR5, vif and tat/rev Genes for an HIV-1 Gene Therapy Approach. Spanevello F; Calistri A; Del Vecchio C; Mantelli B; Frasson C; Basso G; Palù G; Cavazzana M; Parolin C Mol Ther Nucleic Acids; 2016 Apr; 5(4):e312. PubMed ID: 27093170 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages. Surdo M; Balestra E; Saccomandi P; Di Santo F; Montano M; Di Carlo D; Sarmati L; Aquaro S; Andreoni M; Svicher V; Perno CF; Ceccherini-Silberstein F PLoS One; 2013; 8(7):e68076. PubMed ID: 23874501 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection. Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597 [TBL] [Abstract][Full Text] [Related]
14. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors. Pontow S; Ratner L J Virol; 2001 Dec; 75(23):11503-14. PubMed ID: 11689632 [TBL] [Abstract][Full Text] [Related]
15. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy. Bai J; Rossi J; Akkina R AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007 [TBL] [Abstract][Full Text] [Related]
16. Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-tropic HIV. Cordelier P; Morse B; Strayer DS Oligonucleotides; 2003; 13(5):281-94. PubMed ID: 15000819 [TBL] [Abstract][Full Text] [Related]
17. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Qin XF; An DS; Chen IS; Baltimore D Proc Natl Acad Sci U S A; 2003 Jan; 100(1):183-8. PubMed ID: 12518064 [TBL] [Abstract][Full Text] [Related]
18. Concordant utilization of macrophage entry coreceptors by related variants within an HIV type 1 primary isolate viral swarm. Singh A; Yi Y; Isaacs SN; Kolson DL; Collman RG AIDS Res Hum Retroviruses; 2001 Jul; 17(10):957-63. PubMed ID: 11461681 [TBL] [Abstract][Full Text] [Related]
19. Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection. Cashin K; Jakobsen MR; Sterjovski J; Roche M; Ellett A; Flynn JK; Borm K; Gouillou M; Churchill MJ; Gorry PR Retrovirology; 2013 Sep; 10():98. PubMed ID: 24041034 [TBL] [Abstract][Full Text] [Related]
20. Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives. Utaipat U; Duerr A; Rudolph DL; Yang C; Butera ST; Lupo D; Pisell T; Tangmunkongvorakul A; Kamtorn N; Nantachit N; Nagachinta T; Suriyanon V; Robison V; Nelson KE; Sittisombut N; Lal RB AIDS Res Hum Retroviruses; 2002 Jan; 18(1):1-11. PubMed ID: 11804551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]